Emily earned a Bachelor of Science in biotechnology from Rochester Institute of Technology in 2018, and a Master of Science in biomedical sciences with a focus in pharmacology from University of Colorado Anschutz Medical Campus in 2020. During her thesis work, she studied non-small cell lung cancer and how the immune system plays a role in response to different therapies. Emily is passionate about immunology, cancer biology, and molecular biology, and understanding how they relate to diseases.
Rochester Institute of Technology (B.S. in biotechnology)
University of Colorado Anschutz Medical Campus (M.S. in biomedical sciences, focus on pharmacology)
MyMyelomaTeam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment.
No information on MyMyelomaTeam should be construed as medical and/or health advice.